Esperion Therapeutics, Inc

(NASDAQ:ESPR)

Latest On Esperion Therapeutics, Inc (ESPR):

Date/Time Type Description Signal Details
2023-05-10 02:32 ESTNewsEsperion Therapeutics, Inc. (ESPR) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 12:55 ESTNewsEsperion Therapeutics GAAP EPS of -$0.79 misses by $0.14, revenue of $24.33M beats by $2.36MN/A
2023-05-02 22:13 ESTNewsEsperion Therapeutics: A Speculative Buy Amidst Extreme PessimismN/A
2023-04-19 22:30 ESTNewsEsperion, Currax team up to co-promote cholesterol lowering drug NexletolN/A
2023-03-20 12:57 ESTNewsEsperion in red on pricing $56.7M in stock and short-term warrants offeringN/A
2023-03-16 17:34 ESTNewsEsperion extends selloff as Daiichi Sankyo dispute prompts BofA downgradeN/A
2023-03-16 17:34 ESTNewsHot Stocks: PATH, SIG, PD rises on earnings; INTC, QCOM, SWKS upgraded at Susquehanna, FRC, HALO ESPR slideN/A
2023-03-16 02:22 ESTNewsEsperion Therapeutics falls 55% in dustup with Daiichi Sankyo over milestone paymentsN/A
2023-03-07 19:04 ESTNewsEsperion upgraded at Credit Suisse despite selloff after Nexletol dataN/A
2023-03-06 13:47 ESTNewsEsperion stock slumps ~20% amid Nexletol data showing reduced risk of heart eventsN/A
2023-02-22 00:04 ESTNewsEsperion Therapeutics, Inc. (ESPR) Q4 2022 Earnings Call TranscriptN/A
2023-02-21 10:46 ESTNewsEsperion Therapeutics GAAP EPS of -$0.76 beats by $0.09, revenue of $18.8M misses by $1.8MN/A
2023-02-20 21:37 ESTNewsEsperion Therapeutics Q4 2022 Earnings PreviewN/A
2023-02-10 13:15 ESTNewsEsperion Therapeutics: Price Response From Nexletol Data Illustrates Market Expects MoreN/A
2023-01-09 03:44 ESTNewsEsperion sees preliminary Q4 U.S. net product revenue $14.4M-$15.1MN/A
2022-12-07 12:02 ESTNewsEsperion Nexletol helps cut cardiovascular events in phase 3 trialN/A
2022-11-17 04:17 ESTNewsBen Halladay appointed CFO of EsperionN/A
2022-11-16 11:24 ESTNewsEsperion Therapeutics: Q3 Earnings Reveal Progress Ahead Of CLEAR Outcomes DataN/A
2022-11-02 01:22 ESTNewsEsperion Therapeutics, Inc. (ESPR) Q3 2022 Earnings Call TranscriptN/A
2022-11-01 09:07 ESTNewsEsperion Therapeutics GAAP EPS of -$0.81 beats by $0.12, revenue of $19M misses by $0.68MN/A
2022-10-31 17:42 ESTNewsEsperion Therapeutics Q3 2022 Earnings PreviewN/A
2022-08-26 20:53 ESTNewsEsperion says Nexletol recommended as oral non-statin therapy for lowering cholesterolN/A
2022-08-09 02:08 ESTNewsEsperion Therapeutics: Positive Update On CLEAR Outcomes Trial Offsets Mixed Q2 EarningsN/A
2022-08-03 20:24 ESTNewsEsperion downgraded at Credit Suisse citing limited upside until key readoutN/A
2022-08-02 14:58 ESTNewsEsperion Therapeutics GAAP EPS of -$1.05 misses by $0.13, revenue of $18.84M beats by $0.22MN/A
2022-08-02 14:57 ESTNewsEsperion Therapeutics, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-02 14:57 ESTNewsEsperion stock rises as Q2 product revenue grows 28% Y/YN/A
2022-08-02 14:56 ESTNewsEsperion Therapeutics, Inc. (ESPR) CEO Sheldon Koenig on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-02 00:57 ESTNewsEsperion Therapeutics Q2 2022 Earnings PreviewN/A
2022-05-07 01:49 ESTNewsEsperion Therapeutics: 2021 Labors Paying Off In 2022N/A
2022-05-04 06:20 ESTNewsEsperion Therapeutics, Inc. (ESPR) CEO Sheldon Koenig on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 06:19 ESTNewsEsperion Therapeutics, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-03 13:09 ESTNewsEsperion Therapeutics GAAP EPS of -$0.93 beats by $0.11, revenue of $18.83M beats by $3.42MN/A
2022-05-03 13:09 ESTNewsEsperion stock rises as Q1 revenue soars 136% Y/YN/A
2022-05-02 19:42 ESTNewsEsperion Therapeutics Q1 2022 Earnings PreviewN/A
2022-03-15 23:30 ESTNewsEsperion says CFO is stepping down next monthN/A
2022-03-10 15:40 ESTNewsEsperion earns positive views at H.C. Wainwright on prospects for cholesterol drugsN/A
2022-02-26 02:55 ESTNewsEsperion Therapeutics, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-25 07:47 ESTNewsEsperion Therapeutics: Ready For Growth Ahead Of Clear Outcomes Topline Data ReadoutN/A
2022-02-22 23:57 ESTNewsEsperion Therapeutics GAAP EPS of -$1.77 beats by $0.52, revenue of $15.4M beats by $0.92MN/A
2022-02-22 23:56 ESTNewsEsperion stock rises 12% as FY21 net product sales soar 209% Y/YN/A
2022-02-22 23:56 ESTNewsEsperion Therapeutics, Inc. (ESPR) CEO Sheldon Koenig on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-18 13:34 ESTNewsEsperion Therapeutics Q4 2021 Earnings PreviewN/A
2022-01-21 10:40 ESTNewsEsperion Therapeutics - A Glimmer Of Light At The End Of The TunnelN/A
2022-01-20 03:54 ESTNewsEsperion Therapeutics: A Potential 'Bio Boom' Or Bust In 2022N/A
2021-12-03 13:30 ESTNewsEsperion slips on stock and warrants offeringN/A
2021-12-03 13:30 ESTNewsEsperion raises $225M capital via stock offeringN/A
2021-11-06 01:15 ESTNewsEsperion Therapeutics, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-02 15:46 ESTNewsEsperion Therapeutics EPS beats by $0.22, beats on revenueN/A
2021-11-02 15:45 ESTNewsEsperion Q3 2021 earnings beat helped by rising sales of cholesterol-lowering drugsN/A

About Esperion Therapeutics, Inc (ESPR):

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low-density lipoprotein cholesterol in the United States and internationally. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

ESPR Quotes by TradingView

See Advanced Chart

General

  • Name Esperion Therapeutics, Inc
  • Symbol ESPR
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 479
  • Last Split Factor1:6
  • Last Split Date2013-06-11
  • Fiscal Year EndDecember
  • IPO Date2013-06-26
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.esperion.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 3.55
  • Price/Book (Most Recent Quarter) 98.42
  • Enterprise Value Revenue 3.17
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$9.58
  • Next Year EPS Estimate -$3.37
  • Next Quarter EPS Estimate -$2.07
  • Profit Margin -63%
  • Operating Margin -53%
  • Return on Assets -27%
  • Return on Equity -261%
  • Revenue 227.55 million
  • Earnings Per Share -$2.86
  • Revenue Per Share $8.28
  • Gross Profit 78.22 million
  • Quarterly Earnings Growth 881.5%
View More

Highlights

  • Market Capitalization 791.61 million
  • EBITDA -79313000
  • PE Ratio -1.8
  • PEG Ratio -4.78
  • Analyst Target Price $65.55
  • Book Value Per Share $0.32
View More

Share Statistics

  • Shares Outstanding 27.94 million
  • Shares Float 26.11 million
  • % Held by Insiders 85%
  • % Held by Institutions 122.14%
  • Shares Short 10.11 million
  • Shares Short Prior Month 9.55 million
  • Short Ratio 10.02
  • Short % of Float 42%
  • Short % of Shares Outstanding 36%
View More

Technicals

  • Beta 1.24
  • 52 Week High $53.73
  • 52 Week Low $23.9
  • 50 Day Moving Average 30.52
  • 200 Day Moving Average 31.07
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Esperion Therapeutics, Inc (ESPR) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Esperion Therapeutics, Inc (ESPR) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-23$9.64 million-$3.89-$3.992.42%
2020-09-302020-11-02$N/A-$3.07-$3.5714.12%
2020-06-302020-08-10$N/A$4.32$1.40209.43%
2020-03-312020-05-06$N/A-$2.84-$3.2412.22%
2019-12-312020-02-27$982000-$2.26-$2.6715.26%
2019-09-302019-11-06$981000-$2.52-$1.92-30.97%
2019-06-302019-08-08$982000-$2.01-$1.82-10.71%
2019-03-312019-05-08$145.42 million$3.07$0.86255.9%
2018-12-312019-02-28$N/A-$2.24-$1.12-100.7%
2018-09-302018-11-01$N/A-$1.86-$1.64-13.44%
2018-06-302018-08-02$N/A-$1.71-$1.720.52%
2018-03-312018-05-02$N/A-$1.73-$1.59-8.87%
2017-12-312018-02-20$N/A-$1.44-$1.7718.42%
2017-09-302017-11-07$N/A-$1.86-$1.77-4.95%
2017-06-302017-08-08$N/A-$1.92-$1.62-18.72%
2017-03-312017-05-04$N/A-$1.80-$1.46-23.55%
2016-12-312017-02-22$N/A-$1.29-$1.24-3.69%
2016-09-302016-11-03$N/A-$0.77-$0.847.88%
2016-06-302016-08-04$N/A-$0.62-$0.7719.79%
2016-03-312016-05-04$N/A-$0.65-$0.7311.25%
2015-12-312016-02-25$N/A-$0.58-$0.649.57%
2015-09-302015-11-05$N/A-$0.57-$0.605%
2015-06-302015-08-06$N/A-$0.55-$0.585.17%
2015-03-312015-05-07$N/A-$0.56-$0.48-16.67%
2014-12-312015-03-05$N/A-$0.49-$0.5510.91%
2014-09-302014-11-10$N/A-$0.64-$0.685.88%
2014-06-302014-08-12$N/A-$0.60-$0.600%
2014-03-312014-05-12$N/A-$0.51-$0.6217.74%
2013-12-312014-03-05$N/A-$0.63-$0.50-26%
2013-09-302013-11-06$N/A-$0.34-$0.4015%
2013-06-302013-08-12$N/A-$19.82

Esperion Therapeutics, Inc (ESPR) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Esperion Therapeutics, Inc (ESPR) Chart:

Esperion Therapeutics, Inc (ESPR) News:

Below you will find a list of latest news for Esperion Therapeutics, Inc (ESPR) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Esperion Therapeutics, Inc (ESPR) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-170.50CALL0 01196.01TRUE00
2024-05-1711.2CALL1 0434.41TRUE1.20
2024-05-171.50.5CALL58 2170.37TRUE0.50
2024-05-1720.22CALL135 1112116.82FALSE-0.08-0.27
2024-05-172.50.08CALL48 1948120.61FALSE-0.04-0.33
2024-05-1730.05CALL7 2144145.03FALSE-0.01-0.17
2024-05-173.50.04CALL0 13020FALSE00
2024-05-1740.05CALL0 6550FALSE00
2024-05-174.50.15CALL0 3950FALSE00
2024-05-1750.07CALL0 9010FALSE00
2024-05-175.50.08CALL0 4100FALSE00
2024-05-170.50.03PUT0 70FALSE00
2024-05-1710.04PUT0 300FALSE00
2024-05-171.50.1PUT0 3090FALSE00
2024-05-1720.2PUT91 1344103.95TRUE0.010.05
2024-05-172.50.55PUT1 135697.18TRUE0.050.1
2024-05-1730.94PUT0 605212.89TRUE00
2024-05-173.51.63PUT0 10252.63TRUE00
2024-05-1740PUT0 0267.64TRUE00
2024-05-174.50PUT0 0359.39TRUE00
2024-05-1750PUT0 0367.97TRUE00
2024-05-175.50PUT0 0317.04TRUE00
2024-06-210.50CALL0 00TRUE00
2024-06-2111CALL0 830176.36TRUE00
2024-06-211.50.65CALL50 74127.9TRUE0.650
2024-06-2120.35CALL92 6395112.56FALSE-0.1-0.22
2024-06-212.50.18CALL100 2172108.61FALSE-0.07-0.28
2024-06-2130.1CALL111 8150110.98FALSE-0.06-0.38
2024-06-213.50.05CALL0 2301122.29FALSE00
2024-06-2140.06CALL22 2960131.95FALSE-0.04-0.4
2024-06-214.50.2CALL0 4120FALSE00
2024-06-2150.05CALL0 27400FALSE00
2024-06-215.50.2CALL0 190FALSE00
2024-06-2160.08CALL0 2030FALSE00
2024-06-2170CALL0 00FALSE00
2024-06-210.50PUT0 00FALSE00
2024-06-2110.05PUT0 18710FALSE00
2024-06-211.50.15PUT0 175117.38FALSE00
2024-06-2120.32PUT50 1146104.45TRUE0.040.14
2024-06-212.50.75PUT0 317117.87TRUE00
2024-06-2131.15PUT200 948134.03TRUE1.150
2024-06-213.50.77PUT0 30168.63TRUE00
2024-06-2141.57PUT0 85132.36TRUE00
2024-06-214.50PUT0 0293.35TRUE00
2024-06-2152.52PUT0 399333.55TRUE00
2024-06-215.50PUT0 0244.96TRUE00
2024-06-2160PUT0 0327.43TRUE00
2024-06-2170PUT0 0479.27TRUE00
2024-09-200.51.42CALL0 10TRUE00
2024-09-2011.35CALL0 2409.06TRUE00
2024-09-201.50.75CALL0 20475.31TRUE00
2024-09-2020.5CALL3 346114.19FALSE0.50
2024-09-202.50.45CALL0 798109.51FALSE00
2024-09-2030.35CALL0 1563105.82FALSE00
2024-09-203.50.23CALL20 263112.19FALSE-0.08-0.26
2024-09-2040.15CALL5 1066106.16FALSE-0.1-0.4
2024-09-204.50.11CALL90 150105.45FALSE0.110
2024-09-2050.11CALL0 82110.78FALSE00
2024-09-205.50CALL0 0109.67FALSE00
2024-09-2060.3CALL0 90FALSE00
2024-09-2070.53CALL0 30FALSE00
2024-09-200.50PUT0 00FALSE00
2024-09-2010.11PUT0 117109.46FALSE00
2024-09-201.50.32PUT0 97115.49FALSE00
2024-09-2020.48PUT0 269114.97TRUE00
2024-09-202.50.8PUT0 157116.6TRUE00
2024-09-2031PUT0 132109.06TRUE00
2024-09-203.51.7PUT0 71109.97TRUE00
2024-09-2042.05PUT0 24123.66TRUE00
2024-09-204.50PUT0 0129.28TRUE00
2024-09-2052.17PUT0 5109.86TRUE00
2024-09-205.50PUT0 0134.67TRUE00
2024-09-2060PUT0 0142.48TRUE00
2024-09-2070PUT0 0138.99TRUE00
2024-12-200.50CALL0 00TRUE00
2024-12-2010CALL0 0241.84TRUE00
2024-12-201.50CALL0 0105.66TRUE00
2024-12-2020.85CALL0 451127.35FALSE00
2024-12-202.50.6CALL10 0116.43FALSE0.60
2024-12-2030.55CALL0 1000FALSE00
2024-12-203.50.35CALL0 11110.65FALSE00
2024-12-200.50PUT0 00FALSE00
2024-12-2010PUT0 0122.54FALSE00
2024-12-201.50PUT0 0119.13FALSE00
2024-12-2020PUT0 0109.71TRUE00
2024-12-202.50PUT0 0110.31TRUE00
2024-12-2031.29PUT0 2112.93TRUE00
2024-12-203.50PUT0 0111.34TRUE00
2025-01-170.51.55CALL0 20223.16TRUE00
2025-01-1711.35CALL0 2122161.96TRUE00
2025-01-171.50.88CALL0 4957.81TRUE00
2025-01-1720.8CALL0 21747103.2FALSE00
2025-01-172.50.7CALL0 27190.89FALSE00
2025-01-1730.45CALL20 4259103.28FALSE0.450
2025-01-173.50.45CALL0 175893.05FALSE00
2025-01-1740.35CALL10 2757110.32FALSE0.350
2025-01-174.50.3CALL0 1098.55FALSE00
2025-01-1750.25CALL11 1680109.44FALSE0.250
2025-01-175.50.23CALL0 106106.7FALSE00
2025-01-1770.16CALL0 2068110.87FALSE00
2025-01-17100.15CALL0 1570110.57FALSE00
2025-01-170.50.05PUT0 350FALSE00
2025-01-1710.23PUT0 626124.07FALSE00
2025-01-171.50.4PUT0 83113.25FALSE00
2025-01-1720.7PUT0 1531112.77TRUE00
2025-01-172.51.05PUT0 2475112.8TRUE00
2025-01-1731.45PUT0 3077107.8TRUE00
2025-01-173.51.8PUT1 35106.45TRUE1.80
2025-01-1742.15PUT0 34109.85TRUE00
2025-01-174.52.7PUT0 11106.89TRUE00
2025-01-1753.2PUT0 25110.54TRUE00
2025-01-175.50PUT0 0107.89TRUE00
2025-01-1775.03PUT0 119125.38TRUE00
2025-01-17108PUT0 19187.98TRUE00
2026-01-160.52.05CALL0 160TRUE00
2026-01-1612.1CALL0 70TRUE00
2026-01-161.51.3CALL0 770TRUE00
2026-01-1621.25CALL0 7760FALSE00
2026-01-162.51.1CALL0 305150.19FALSE00
2026-01-1630.55CALL0 1550FALSE00
2026-01-163.51.9CALL0 400FALSE00
2026-01-1640.67CALL0 370FALSE00
2026-01-164.51.17CALL0 20FALSE00
2026-01-1650.65CALL0 113105.94FALSE00
2026-01-165.50CALL0 00FALSE00
2026-01-1671.5CALL0 400FALSE00
2026-01-160.50.1PUT0 30111.64FALSE00
2026-01-1610.35PUT0 10109.81FALSE00
2026-01-161.50.68PUT0 51114FALSE00
2026-01-1620.87PUT0 5108.27TRUE00
2026-01-162.51.15PUT0 64109.19TRUE00
2026-01-1631.51PUT0 17107.72TRUE00
2026-01-163.50PUT0 0107.29TRUE00
2026-01-1642.27PUT0 199100.45TRUE00
2026-01-164.52.9PUT3 3102.74TRUE2.90
2026-01-1653.1PUT0 4109.09TRUE00
2026-01-165.53.86PUT0 7104.36TRUE00
2026-01-1674.6PUT0 10101.55TRUE00

Latest ESPR Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$5.325
Jun 13, 2022 7:59 PM EST3$5.315
Jun 13, 2022 7:59 PM EST23$5.31
Jun 13, 2022 7:59 PM EST33$5.31
Jun 13, 2022 7:59 PM EST271$5.3

Esperion Therapeutics, Inc (ESPR) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465920075454/0001104659-20-075454-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434868/000009375119000218/0000093751-19-000218-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434868/000009375120000572/0000093751-20-000572-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434868/000021545719004030/0000215457-19-004030-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434868/000083423720005226/0000834237-20-005226-index.htm
2018-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000089924318015413/0000899243-18-015413-index.htm
2018-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000089924318015926/0000899243-18-015926-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000089924318017843/0000899243-18-017843-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000089924318019108/0000899243-18-019108-index.htm
2018-07-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000089924318019836/0000899243-18-019836-index.htm
2018-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000089924318021471/0000899243-18-021471-index.htm
2018-10-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000089924318027664/0000899243-18-027664-index.htm
2018-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000089924318028245/0000899243-18-028245-index.htm
2018-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000089924318031388/0000899243-18-031388-index.htm
2018-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000089924318031655/0000899243-18-031655-index.htm
2019-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000089924319000685/0000899243-19-000685-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000089924319008014/0000899243-19-008014-index.htm
2019-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000089924319020344/0000899243-19-020344-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000089924319022997/0000899243-19-022997-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000089924319026965/0000899243-19-026965-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000089924320002016/0000899243-20-002016-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000089924320030389/0000899243-20-030389-index.htm
2020-06-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434868/000090266420002409/0000902664-20-002409-index.htm
2018-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000090445418000441/0000904454-18-000441-index.htm
2019-03-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000090445419000335/0000904454-19-000335-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000090445419000452/0000904454-19-000452-index.htm
2019-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434868/000093247119005320/0000932471-19-005320-index.htm
2019-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1434868/000104746919000791/0001047469-19-000791-index.htm
2019-04-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1434868/000104746919002382/0001047469-19-002382-index.htm
2020-04-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1434868/000104746920002363/0001047469-20-002363-index.htm
2018-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465918036424/0001104659-18-036424-index.htm
2018-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465918036428/0001104659-18-036428-index.htm
2018-08-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465918048976/0001104659-18-048976-index.htm
2018-08-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434868/000110465918049208/0001104659-18-049208-index.htm
2018-08-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465918053610/0001104659-18-053610-index.htm
2018-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465918064280/0001104659-18-064280-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465918065425/0001104659-18-065425-index.htm
2018-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434868/000110465918065428/0001104659-18-065428-index.htm
2018-12-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1434868/000110465918074492/0001104659-18-074492-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465918074494/0001104659-18-074494-index.htm
2019-01-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465919000686/0001104659-19-000686-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465919011580/0001104659-19-011580-index.htm
2019-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465919027153/0001104659-19-027153-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465919027675/0001104659-19-027675-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434868/000110465919027829/0001104659-19-027829-index.htm
2019-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465919032757/0001104659-19-032757-index.htm
2019-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465919032758/0001104659-19-032758-index.htm
2019-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465919037687/0001104659-19-037687-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465919044717/0001104659-19-044717-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465919060282/0001104659-19-060282-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434868/000110465919060531/0001104659-19-060531-index.htm
2020-01-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465920009245/0001104659-20-009245-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434868/000110465920017480/0001104659-20-017480-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434868/000110465920021674/0001104659-20-021674-index.htm
2020-02-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465920023959/0001104659-20-023959-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465920025720/0001104659-20-025720-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1434868/000110465920026203/0001104659-20-026203-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1434868/000110465920026249/0001104659-20-026249-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465920034995/0001104659-20-034995-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465920043386/0001104659-20-043386-index.htm
2020-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465920044930/0001104659-20-044930-index.htm
2020-04-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465920048477/0001104659-20-048477-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465920057439/0001104659-20-057439-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434868/000110465920057549/0001104659-20-057549-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465920067802/0001104659-20-067802-index.htm
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465920075454/0001104659-20-075454-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000110465920092733/0001104659-20-092733-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434868/000110465920092840/0001104659-20-092840-index.htm
2020-08-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1434868/000110465920092842/0001104659-20-092842-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434868/000114036119003226/0001140361-19-003226-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434868/000114036120003385/0001140361-20-003385-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434868/000114420419008385/0001144204-19-008385-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911018007562/0001179110-18-007562-index.htm
2018-05-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911018007617/0001179110-18-007617-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911018007618/0001179110-18-007618-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911018008309/0001179110-18-008309-index.htm
2018-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911018010751/0001179110-18-010751-index.htm
2018-08-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911018010995/0001179110-18-010995-index.htm
2018-10-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911018012267/0001179110-18-012267-index.htm
2018-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911018012494/0001179110-18-012494-index.htm
2018-11-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911018013332/0001179110-18-013332-index.htm
2018-11-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911018013333/0001179110-18-013333-index.htm
2018-11-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911018013334/0001179110-18-013334-index.htm
2018-12-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911018014234/0001179110-18-014234-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911019003860/0001179110-19-003860-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911019003861/0001179110-19-003861-index.htm
2019-03-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911019004148/0001179110-19-004148-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911019004415/0001179110-19-004415-index.htm
2019-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911019004803/0001179110-19-004803-index.htm
2019-05-313Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911019006913/0001179110-19-006913-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911019006914/0001179110-19-006914-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911019006915/0001179110-19-006915-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911019006916/0001179110-19-006916-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911019006917/0001179110-19-006917-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911019006918/0001179110-19-006918-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911019006919/0001179110-19-006919-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911019006920/0001179110-19-006920-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911019008245/0001179110-19-008245-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911019009022/0001179110-19-009022-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911019010157/0001179110-19-010157-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911019011560/0001179110-19-011560-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911020000169/0001179110-20-000169-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911020000170/0001179110-20-000170-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911020000171/0001179110-20-000171-index.htm
2020-02-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911020002597/0001179110-20-002597-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911020002647/0001179110-20-002647-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911020003507/0001179110-20-003507-index.htm
2020-03-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911020003875/0001179110-20-003875-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911020006246/0001179110-20-006246-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911020006714/0001179110-20-006714-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911020006715/0001179110-20-006715-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911020006716/0001179110-20-006716-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911020006717/0001179110-20-006717-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911020006718/0001179110-20-006718-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911020006719/0001179110-20-006719-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911020006720/0001179110-20-006720-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1434868/000117911020006721/0001179110-20-006721-index.htm
2018-10-30SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434868/000119312518312265/0001193125-18-312265-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434868/000119312520037802/0001193125-20-037802-index.htm
2019-01-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434868/000138233319000007/0001382333-19-000007-index.htm
2020-01-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1434868/000138233320000003/0001382333-20-000003-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434868/000141057819000732/0001410578-19-000732-index.htm
2019-08-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000141057819000970/0001410578-19-000970-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1434868/000162828020015264/0001628280-20-015264-index.htm
2020-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1434868/000162828020015284/0001628280-20-015284-index.htm
2019-03-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1434868/999999999719001407/9999999997-19-001407-index.htm

Esperion Therapeutics, Inc (ESPR) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Esperion Therapeutics, Inc (ESPR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 85%
Institutional Ownership: 12214%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-03-19NICOLE VITULLODirectorSell1,700.0045.2576,925.000.00https://www.sec.gov/Archives/edgar/data/1434868/000090445419000335/0000904454-19-000335-index.htm
2020-01-02TIMOTHY M MAYLEBENPresident & CEOBuy23,150.00104,498.00https://www.sec.gov/Archives/edgar/data/1434868/000117911020000169/0001179110-20-000169-index.htm
2020-02-28TIMOTHY M MAYLEBENPresident & CEOBuy5,000.0049.00245,000.00109,498.00https://www.sec.gov/Archives/edgar/data/1434868/000117911020002647/0001179110-20-002647-index.htm
2018-11-05Boxer Capital, LLC10% Share HolderSell5,000.0060.28301,400.001,101,250.00https://www.sec.gov/Archives/edgar/data/1434868/000089924318028245/0000899243-18-028245-index.htm
2018-11-05Boxer Capital, LLC10% Share HolderSell13,610.0059.48809,522.801,106,250.00https://www.sec.gov/Archives/edgar/data/1434868/000089924318028245/0000899243-18-028245-index.htm
2020-05-28ANTONIO M JR MD D PHIL GOTTODirectorBuy6,106.0011,073.00https://www.sec.gov/Archives/edgar/data/1434868/000117911020006719/0001179110-20-006719-index.htm
2020-05-28DANIEL JANNEYDirectorBuy6,106.0011,073.00https://www.sec.gov/Archives/edgar/data/1434868/000117911020006718/0001179110-20-006718-index.htm
2020-05-28Jay ShepardDirectorBuy6,106.0011,073.00https://www.sec.gov/Archives/edgar/data/1434868/000117911020006716/0001179110-20-006716-index.htm
2020-05-28Jeffrey BerkowitzDirectorBuy6,106.0011,073.00https://www.sec.gov/Archives/edgar/data/1434868/000117911020006721/0001179110-20-006721-index.htm
2019-04-03Richard BartramChief Financial OfficerSell1,500.0043.6265,430.0011,092.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019004803/0001179110-19-004803-index.htm
2018-11-05Boxer Capital, LLC10% Share HolderSell6,390.0058.82375,859.801,119,860.00https://www.sec.gov/Archives/edgar/data/1434868/000089924318028245/0000899243-18-028245-index.htm
2020-03-11TIMOTHY M MAYLEBENPresident & CEOBuy2,500.0043.00107,500.00111,998.00https://www.sec.gov/Archives/edgar/data/1434868/000117911020003507/0001179110-20-003507-index.htm
2018-11-05Boxer Capital, LLC10% Share HolderSell2,000.0057.38114,760.001,126,250.00https://www.sec.gov/Archives/edgar/data/1434868/000089924318028245/0000899243-18-028245-index.htm
2018-11-05Boxer Capital, LLC10% Share HolderSell6,500.0056.19365,235.001,128,250.00https://www.sec.gov/Archives/edgar/data/1434868/000089924318028245/0000899243-18-028245-index.htm
2018-11-05Boxer Capital, LLC10% Share HolderSell26,500.0055.211,463,065.001,134,750.00https://www.sec.gov/Archives/edgar/data/1434868/000089924318028245/0000899243-18-028245-index.htm
2018-11-02Boxer Capital, LLC10% Share HolderSell37,500.0055.252,071,875.001,161,250.00https://www.sec.gov/Archives/edgar/data/1434868/000089924318028245/0000899243-18-028245-index.htm
2020-05-15Alan FuhrmanDirectorBuy11,003.0011,657.00https://www.sec.gov/Archives/edgar/data/1434868/000117911020006246/0001179110-20-006246-index.htm
2018-11-02Boxer Capital, LLC10% Share HolderSell2,500.0054.65136,625.001,198,750.00https://www.sec.gov/Archives/edgar/data/1434868/000089924318028245/0000899243-18-028245-index.htm
2019-04-03Richard BartramChief Financial OfficerSell6,500.0042.71277,615.0012,592.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019004803/0001179110-19-004803-index.htm
2020-05-28Alan FuhrmanDirectorBuy1,221.0012,878.00https://www.sec.gov/Archives/edgar/data/1434868/000117911020006720/0001179110-20-006720-index.htm
2018-06-06DOV A MD GOLDSTEINDirectorBuy8,000.0017.75142,000.0013,047.00https://www.sec.gov/Archives/edgar/data/1434868/000117911018008309/0001179110-18-008309-index.htm
2019-05-29NICOLE VITULLODirectorBuy4,967.0013,286.00https://www.sec.gov/Archives/edgar/data/1434868/000090445419000452/0000904454-19-000452-index.htm
2020-05-28Tracy M WoodyDirectorBuy6,106.0016,040.00https://www.sec.gov/Archives/edgar/data/1434868/000117911020006714/0001179110-20-006714-index.htm
2020-05-28MARK E MCGOVERNDirectorBuy6,106.0016,073.00https://www.sec.gov/Archives/edgar/data/1434868/000117911020006717/0001179110-20-006717-index.htm
2019-03-19NICOLE VITULLODirectorSell13,629.0044.66608,671.141,700.00https://www.sec.gov/Archives/edgar/data/1434868/000090445419000335/0000904454-19-000335-index.htm
2020-01-02Richard BartramChief Financial OfficerBuy7,525.0018,673.00https://www.sec.gov/Archives/edgar/data/1434868/000117911020000170/0001179110-20-000170-index.htm
2020-05-28NICOLE VITULLODirectorBuy6,106.0019,392.00https://www.sec.gov/Archives/edgar/data/1434868/000117911020006715/0001179110-20-006715-index.htm
2020-01-02Mark A GlickmanChief Commercial OfficerBuy5,925.0025,925.00https://www.sec.gov/Archives/edgar/data/1434868/000117911020000171/0001179110-20-000171-index.htm
2018-06-05TARGET N V BIOTECH10% Share HolderBuy60,000.0038.472,308,440.003,012,964.00https://www.sec.gov/Archives/edgar/data/1434868/000089924318015413/0000899243-18-015413-index.htm
2018-06-07TARGET N V BIOTECH10% Share HolderBuy60,000.0037.792,267,292.003,072,964.00https://www.sec.gov/Archives/edgar/data/1434868/000089924318015926/0000899243-18-015926-index.htm
2018-06-21TARGET N V BIOTECH10% Share HolderBuy60,000.0038.572,314,224.003,132,964.00https://www.sec.gov/Archives/edgar/data/1434868/000089924318017843/0000899243-18-017843-index.htm
2018-06-29TARGET N V BIOTECH10% Share HolderBuy50,000.0039.481,973,805.003,182,964.00https://www.sec.gov/Archives/edgar/data/1434868/000089924318019108/0000899243-18-019108-index.htm
2018-07-12TARGET N V BIOTECH10% Share HolderBuy50,000.0041.772,088,300.003,232,964.00https://www.sec.gov/Archives/edgar/data/1434868/000089924318019836/0000899243-18-019836-index.htm
2018-08-03TARGET N V BIOTECH10% Share HolderBuy50,000.0046.142,306,970.003,282,964.00https://www.sec.gov/Archives/edgar/data/1434868/000089924318021471/0000899243-18-021471-index.htm
2018-12-17TARGET N V BIOTECH10% Share HolderBuy60,000.0047.732,864,070.003,342,964.00https://www.sec.gov/Archives/edgar/data/1434868/000089924318031388/0000899243-18-031388-index.htm
2018-12-24TARGET N V BIOTECH10% Share HolderBuy50,000.0039.911,995,725.003,392,964.00https://www.sec.gov/Archives/edgar/data/1434868/000089924318031655/0000899243-18-031655-index.htm
2019-01-04TARGET N V BIOTECH10% Share HolderBuy80,000.0041.293,303,256.003,472,964.00https://www.sec.gov/Archives/edgar/data/1434868/000089924319000685/0000899243-19-000685-index.htm
2019-03-14TARGET N V BIOTECH10% Share HolderBuy50,000.0049.892,494,355.003,522,964.00https://www.sec.gov/Archives/edgar/data/1434868/000089924319008014/0000899243-19-008014-index.htm
2019-07-23TARGET N V BIOTECH10% Share HolderBuy50,000.0042.652,132,565.003,572,964.00https://www.sec.gov/Archives/edgar/data/1434868/000089924319020344/0000899243-19-020344-index.htm
2019-09-04TARGET N V BIOTECH10% Share HolderBuy80,000.0033.782,702,208.003,652,964.00https://www.sec.gov/Archives/edgar/data/1434868/000089924319022997/0000899243-19-022997-index.htm
2019-11-06TARGET N V BIOTECH10% Share HolderBuy75,000.0037.302,797,560.003,727,964.00https://www.sec.gov/Archives/edgar/data/1434868/000089924319026965/0000899243-19-026965-index.htm
2020-01-23TARGET N V BIOTECH10% Share HolderBuy20,000.0052.121,042,398.003,747,964.00https://www.sec.gov/Archives/edgar/data/1434868/000089924320002016/0000899243-20-002016-index.htm
2020-11-03TARGET N V BIOTECH10% Share HolderBuy200,000.0025.315,062,120.003,947,964.00https://www.sec.gov/Archives/edgar/data/1434868/000089924320030389/0000899243-20-030389-index.htm
2019-05-29ANTONIO M JR MD D PHIL GOTTODirectorBuy4,967.004,967.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019006916/0001179110-19-006916-index.htm
2019-05-29DANIEL JANNEYDirectorBuy4,967.004,967.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019006917/0001179110-19-006917-index.htm
2019-05-29Jay ShepardDirectorBuy4,967.004,967.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019006914/0001179110-19-006914-index.htm
2019-05-29Jeffrey BerkowitzDirectorBuy4,967.004,967.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019006918/0001179110-19-006918-index.htm
2019-05-29Scott BraunsteinDirectorBuy4,967.005,019.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019006919/0001179110-19-006919-index.htm
2018-06-06DOV A MD GOLDSTEINDirectorBuy5,000.0014.4272,100.005,047.00https://www.sec.gov/Archives/edgar/data/1434868/000117911018008309/0001179110-18-008309-index.htm
2019-03-14TIMOTHY M MAYLEBENPresident & CEOBuy5,000.0048.73243,650.0051,163.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019003861/0001179110-19-003861-index.htm
2019-03-12ROGER S NEWTONDirectorSell25,000.0050.061,251,500.00548,726.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019003860/0001179110-19-003860-index.htm
2019-03-20TIMOTHY M MAYLEBENPresident & CEOBuy5,000.0043.48217,400.0056,163.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019004148/0001179110-19-004148-index.htm
2018-11-02ROGER S NEWTONDirectorSell227.0050.7611,522.52573,726.00https://www.sec.gov/Archives/edgar/data/1434868/000117911018012494/0001179110-18-012494-index.htm
2018-11-01ROGER S NEWTONDirectorSell2,600.0050.01130,026.00573,953.00https://www.sec.gov/Archives/edgar/data/1434868/000117911018012494/0001179110-18-012494-index.htm
2018-10-18ROGER S NEWTONDirectorSell100.0050.005,000.00576,553.00https://www.sec.gov/Archives/edgar/data/1434868/000117911018012267/0001179110-18-012267-index.htm
2018-10-17ROGER S NEWTONDirectorSell12,673.0050.02633,903.46576,653.00https://www.sec.gov/Archives/edgar/data/1434868/000117911018012267/0001179110-18-012267-index.htm
2018-10-16ROGER S NEWTONDirectorSell9,400.0050.01470,094.00589,326.00https://www.sec.gov/Archives/edgar/data/1434868/000117911018012267/0001179110-18-012267-index.htm
2018-08-27ROGER S NEWTONDirectorSell12,100.0050.65612,865.00598,726.00https://www.sec.gov/Archives/edgar/data/1434868/000117911018010995/0001179110-18-010995-index.htm
2018-08-27ROGER S NEWTONDirectorSell4,200.0051.46216,132.00610,826.00https://www.sec.gov/Archives/edgar/data/1434868/000117911018010995/0001179110-18-010995-index.htm
2019-03-29TIMOTHY M MAYLEBENPresident & CEOBuy5,000.0040.00200,000.0061,163.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019004415/0001179110-19-004415-index.htm
2018-08-27ROGER S NEWTONDirectorSell700.0052.9137,037.00615,026.00https://www.sec.gov/Archives/edgar/data/1434868/000117911018010995/0001179110-18-010995-index.htm
2018-08-27ROGER S NEWTONDirectorSell700.0053.6837,576.00615,726.00https://www.sec.gov/Archives/edgar/data/1434868/000117911018010995/0001179110-18-010995-index.htm
2018-08-17ROGER S NEWTONDirectorSell7,300.0050.06365,438.00616,426.00https://www.sec.gov/Archives/edgar/data/1434868/000117911018010751/0001179110-18-010751-index.htm
2019-06-28TIMOTHY M MAYLEBENPresident & CEOBuy5,000.0046.00230,000.0066,163.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019008245/0001179110-19-008245-index.htm
2019-08-01TIMOTHY M MAYLEBENPresident & CEOBuy5,000.0039.56197,800.0071,163.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019009022/0001179110-19-009022-index.htm
2019-09-04TIMOTHY M MAYLEBENPresident & CEOBuy4,852.0034.22166,035.4476,015.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019010157/0001179110-19-010157-index.htm
2019-09-04TIMOTHY M MAYLEBENPresident & CEOBuy148.0033.424,946.1676,163.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019010157/0001179110-19-010157-index.htm
2019-09-06TIMOTHY M MAYLEBENPresident & CEOBuy2,500.0035.2588,125.0078,663.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019010157/0001179110-19-010157-index.htm
2019-11-06TIMOTHY M MAYLEBENPresident & CEOBuy5,000.0036.98184,900.0083,663.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019011560/0001179110-19-011560-index.htm
2019-05-29Tracy M WoodyDirectorBuy9,934.009,934.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019006920/0001179110-19-006920-index.htm
2019-05-29MARK E MCGOVERNDirectorBuy4,967.009,967.00https://www.sec.gov/Archives/edgar/data/1434868/000117911019006915/0001179110-19-006915-index.htm